news
A new study shows that the VISTA molecule stops the…
17 January 2020 | By Hannah Balfour (Drug Target Review)
A new study shows that the VISTA molecule stops the immune system responding to self-antigens, including those presented by cancer cells, so an anti-VISTA antibody could be a possible therapy.